Literature DB >> 22414086

The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?

B Jacobs1, E Ullrich.   

Abstract

The crosstalk of natural killer (NK) and dendritic cells (DCs) plays an important role in the induction of the tumor-specific immune response against cancer. During the last decade, our advanced understanding of the immune system led to the development of new therapeutic strategies in the field of immunotherapy and cellular immunology. However, these immunotherapeutic concepts have not been as successful as initially expected because of their inability to counteract cancer-induced immunosuppressive pathways. Some of the major difficulties of effective cellular immunotherapy are the highly immunosuppressive factors induced by tumor cells themselves or by their microenvironment. Therefore, one major challenge in immunotherapy is the question: "How to enforce NK cell & DC action under immunosuppressive conditions?" This review focuses on the current knowledge on the tumor microenvironment, the crosstalk of NK cells and DCs, as well as their deregulation in the complex interplay with the immunosuppressive tumor microenvironment. We further discuss possible strategies to minimize the negative impact of the tumor microenvironment on the immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22414086     DOI: 10.2174/092986712800099857

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  16 in total

1.  Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma.

Authors:  Matthew C Altman; Elizabeth Whalen; Alkis Togias; George T O'Connor; Leonard B Bacharier; Gordon R Bloomberg; Meyer Kattan; Robert A Wood; Scott Presnell; Petra LeBeau; Katy Jaffee; Cynthia M Visness; William W Busse; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2018-03-05       Impact factor: 10.793

Review 2.  The application of tumor cell-derived vesicles in oncology therapy.

Authors:  Ximei Xu; Yin Xiang; Yang Yang; Kai Liu; Zhiwei Cui; Xiaodong Tong; Junliang Chen; Fang Hou; Zhiqiang Luo
Journal:  Clin Transl Oncol       Date:  2022-10-07       Impact factor: 3.340

Review 3.  Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology.

Authors:  Hedi Harizi
Journal:  Cell Mol Immunol       Date:  2013-03-25       Impact factor: 11.530

4.  Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients.

Authors:  Raghvendra M Srivastava; Steve C Lee; Pedro A Andrade Filho; Christopher A Lord; Hyun-Bae Jie; H Carter Davidson; Andrés López-Albaitero; Sandra P Gibson; William E Gooding; Soldano Ferrone; Robert L Ferris
Journal:  Clin Cancer Res       Date:  2013-02-26       Impact factor: 12.531

5.  CD4(+) NKG2D(+) T cells induce NKG2D down-regulation in natural killer cells in CD86-RAE-1ε transgenic mice.

Authors:  Zhijie Lin; Changrong Wang; Haizui Xia; Weiguang Liu; Weiming Xiao; Li Qian; Xiaoqin Jia; Yanbing Ding; Mingchun Ji; Weijuan Gong
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 6.  Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment.

Authors:  Benedikt Jacobs; Veronika Gebel; Lukas Heger; Victoria Grèze; Hansjörg Schild; Diana Dudziak; Evelyn Ullrich
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

7.  Mast cell exosomes promote lung adenocarcinoma cell proliferation - role of KIT-stem cell factor signaling.

Authors:  Hui Xiao; Cecilia Lässer; Ganesh Vilas Shelke; Juan Wang; Madeleine Rådinger; Taral Rameshchand Lunavat; Carina Malmhäll; Li Hui Lin; Jia Li; Li Li; Jan Lötvall
Journal:  Cell Commun Signal       Date:  2014-10-14       Impact factor: 5.712

Review 8.  Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy.

Authors:  Cariad Chester; Katherine Fritsch; Holbrook E Kohrt
Journal:  Front Immunol       Date:  2015-12-02       Impact factor: 7.561

9.  Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol.

Authors:  Ulrike Koehl; Claudia Brehm; Sabine Huenecke; Stefanie-Yvonne Zimmermann; Stephan Kloess; Melanie Bremm; Evelyn Ullrich; Jan Soerensen; Andrea Quaiser; Stephanie Erben; Claudia Wunram; Tanja Gardlowski; Eileen Auth; Torsten Tonn; Christian Seidl; Sandrine Meyer-Monard; Martin Stern; Jakob Passweg; Thomas Klingebiel; Peter Bader; Dirk Schwabe; Ruth Esser
Journal:  Front Oncol       Date:  2013-05-17       Impact factor: 6.244

Review 10.  Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy.

Authors:  Raquel Tarazona; Esther Duran; Rafael Solana
Journal:  Front Immunol       Date:  2016-01-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.